Impact of AI-based Dose Optimization in Radiography at St. Mary's Hospital Radiology Department
Table Of Contents
Chapter ONE
INTRODUCTION
- 1.1Introduction
- 1.2Background of the Study
- 1.3Statement of the Problem
- 1.4Aim and Objectives of the Study
- 1.5Research Questions
- 1.6Research Hypotheses
- 1.7Significance of the Study
- 1.8Scope and Delimitation of the Study
- 1.9Limitations of the Study
- 1.10Organisation of the Study
- 1.11Operational Definition of Terms
Chapter TWO
LITERATURE REVIEW
- 2.1Conceptual Review: AI-driven Dose Optimization in Radiography
- 2.2Conceptual Review: Image Quality and Radiation Safety Interplay
- 2.3Theoretical Framework: Technology Acceptance Model (TAM) and Unified Theory of Acceptance and Use of Technology (UTAUT)
- 2.4Theoretical Framework: Radiobiological Principles and ALARA
- 2.5Empirical Review: Dose Optimization Algorithms in Diagnostic Radiography
- 2.6Empirical Review: AI-based Protocol Standardization in Clinical Radiography
- 2.7Empirical Review: Real-world Deployment Challenges in Hospital Radiology
- 2.8Empirical Review: Equipment Vendor and Workflow Integration Effects
2.9Gaps in the Literature: Real-world Validation in Urban Hospital Settings
2.10Gaps in the Literature: Patient-throughput vs. Image Quality Trade-offs
2.11Gaps in the Literature: Ethical and Legal Considerations in AI Dose Optimisation
- 2.12Conceptual Model: AI Dose Optimization in a Hospital Radiology Department
- 2.13Summary of the Literature Review
Chapter THREE
RESEARCH METHODOLOGY
- 3.1Research Design: Case-study Approach within St. Mary’s Hospital Radiology Department
- 3.2Philosophical Paradigm: Pragmatism and Mixed Methods Justification
- 3.3Population of the Study: Radiographers, Radiologists, and Medical Physicists at St. Mary’s
- 3.4Sample Size and Sampling Technique: Purposive and Stratified Sampling for Staff and Patients
- 3.5Sources and Instruments of Data Collection: System Logs, Dose Records, Interviews, and Surveys
- 3.6Validity and Reliability of Instruments: Pilot Testing, Triangulation, and Inter-rater Reliability
- 3.7Data Collection Procedures: Ethical Approvals, Access, and Data Handling
- 3.8Data Analysis Techniques: Descriptive Statistics, Inferential Tests, and Thematic Analysis
- 3.9Model Specification: Dose-Optimization Algorithm Performance Metrics and Regression Models
- 3.10Ethical Considerations: Informed Consent, Anonymization, and Data Security
Chapter FOUR
DATA PRESENTATION AND ANALYSIS
- ANALYSIS AND DISCUSSION OF FINDINGS
- 4.1Data Presentation: Departmental Workflow and AI System Integration Overview
- 4.2Descriptive Analysis: Baseline Radiography Dosage, Protocol Adherence, and Image Quality Scores
- 4.3Inferential Analysis: Impact of AI Dose Optimization on Effective Dose and Reference Dose Indices
- 4.4Hypotheses Testing: Differences in Patient Dose Before and After AI Implementation
- 4.5Subgroup Analyses: By Exam Type, Age Group, and Imaging Modality
- 4.6Clinical Workflow Impact: Throughput, Recall Rates, and Repeats
- 4.7Operator Acceptance and Usability: Radiographer and Radiologist Perspectives
- 4.8Discussion: Integration with ALARA Principles and Patient Safety Outcomes
Chapter FIVE
SUMMARY, CONCLUSION AND RECOMMENDATIONS
- CONCLUSION AND RECOMMENDATIONS
- 5.1Summary of Findings
- 5.2Conclusion: AI Dose Optimization Efficacy in St. Mary’s Radiology Department
- 5.3Contribution to Knowledge: Practical and Theoretical Implications
- 5.4Recommendations: For Clinical Practice, Training, and System Upgrades
- 5.5Suggestions for Further Studies
Thesis Abstract
This study investigates the impact of AI-based dose optimization on radiographic imaging practices within St. Mary’s Hospital Radiology Department, addressing the persistent challenge of balancing diagnostic image quality with patient radiation exposure in a high-volume clinical setting. The problem centers on the variability of dose recommendations across conventional protocols and the potential of AI-driven algorithms to standardize exposure while preserving diagnostic accuracy, thereby reducing cumulative patient dose and optimizing workflow efficiency. The aim is to evaluate (1) changes in patient- and procedure-specific radiation dose metrics, (2) the effect on image quality and diagnostic confidence, (3) technologist workflow efficiency, and (4) stakeholder acceptance and perceived usability of AI-based dose optimization tools. Specific objectives include quantifying dose metrics (CTDIvol, DLP, and ionizing radiation dose per radiograph) before and after AI implementation; assessing image quality using standardized metrics and blinded radiologist scoring; examining changes in repeat-rate and examination turnaround times; analyzing technologist satisfaction and perceived usability through validated surveys; and exploring barriers to adoption via semi-structured interviews under a theoretical lens of Technology Acceptance Model (TAM) and Diffusion of Innovations (DOI). The methodology adopts a mixed-methods, longitudinal, quasi-experimental design conducted over 18 months, comprising a 6-month pre-implementation baseline and a 12-month post-implementation period. The population includes all radiographic procedures performed in the department, with a purposive sample of 1,200 adult radiographs across chest, abdomen, and extremity studies for quantitative dose and image-quality analysis, and a convenience sample of 40 radiographers for workflow and usability assessments. Data collection instruments include automated dose records from the Radiology Information System (RIS) and Picture Archiving and Communication System (PACS); a standardized image-quality assessment protocol using a 5-point Likert scale validated by prior studies; a technologist workflow survey measuring turnaround times and satisfaction; and semi-structured interview guides aligned with TAM and DOI constructs. Instrument validity is ensured through expert panel review and pilot testing with 5 radiographs per modality, and reliability is established via Cronbach’s alpha for survey scales and inter-rater agreement (Cohen’s kappa) for image-quality scoring. Data analysis employs a two-pronged approach. Quantitative analysis uses descriptive statistics to summarize dose metrics and image-quality scores, paired-sample t-tests or Wilcoxon signed-rank tests for pre- vs post-implementation comparisons, and multivariate linear regression to adjust for confounders such as patient thickness, technique factors, and modality. Repeated-measures ANOVA will examine trajectory effects over time. Mediation analysis will explore whether improvements in diagnostic confidence mediate the relationship between dose optimization and clinical outcomes. Qualitative data from interviews will be analyzed thematically using a priori codes informed by TAM and DOI, with triangulation against quantitative findings to enhance validity. The analysis will be conducted with R and NVivo software, ensuring transparency via preregistered analytic plan and data management procedures. Key expected findings include a statistically significant reduction in mean dose per examination (anticipated 15–25% decline in CTDIvol and DLP for CT-related studies; 10–20% for radiographs), without compromising image quality or diagnostic accuracy, and a reduction in repeat rates by 8–15%. Technologist workflow efficiency is anticipated to improve, evidenced by shorter procedure times and higher satisfaction scores. The study also expects to identify key determinants of AI adoption, with TAM demonstrating perceived usefulness and perceived ease of use as primary predictors of intention to use, moderated by organizational support per DOI constructs. The study contributes to knowledge by providing empirical, context-specific evidence on AI-driven dose optimization in a real-world radiology department, offering a rigorous evaluation framework for dose reduction without sacrificing diagnostic integrity, and detailing facilitators and barriers to adoption in a high-demand clinical environment. Practical recommendations include refining automated exposure protocols, targeted training modules for radiographers, ongoing monitoring of dose metrics, and a structured change-management plan to sustain AI-enabled improvements beyond the study period. The findings are expected to inform policy development for dose optimization, guide vendor decision-making for AI radiography solutions, and contribute to best-practice guidelines for radiology departments pursuing responsible, evidence-based dose management.
Thesis Overview
This research investigates how artificial intelligence (AI) can optimize patient radiation dose in radiographic imaging within St. Mary’s Hospital’s Radiology Department. The central idea is that AI tools can learn from historical imaging data to adjust exposure settings in real time, achieving the lowest possible dose without compromising image quality, thereby improving patient safety and diagnostic effectiveness.
Why it matters: Ionizing radiation exposure carries cumulative cancer risk, especially for frequent radiography patients such as oncology, pediatrics, or chronic-condition cohorts. Traditional dose optimization relies on manual protocols and clinician judgment, which can vary and may not adapt to patient-specific factors. AI-based dose optimization has the potential to standardize practices, personalize exposure, and reduce unnecessary dose while maintaining, or even enhancing, diagnostic accuracy.
Problem or knowledge gap: While AI dose optimization shows promise in controlled studies, there is limited evidence on its effectiveness and safety in routine clinical workflows, integration with hospital information systems, and acceptance by radiographers. There is also a need to quantify the trade-offs between dose reduction and image quality across diverse patient populations in a real-world setting.
What the researcher will do, step by step:
- Conduct a situational assessment of current dose practices in St. Mary’s Hospital Radiology Department and establish baseline metrics for dose indicators and image quality.
- Implement an AI-driven dose optimization module integrated with the existing radiography workflow, ensuring patient privacy and data governance.
- Collect retrospective data (n=1,000 exams) and prospective data (n=1,200 exams) before and after AI deployment, including dose metrics (e.g., KAP, DAP), exposure parameters, and image quality scores.
- Analyze data using descriptive statistics to compare pre- and post-implementation dose levels, followed by inferential tests (paired t-tests or Wilcoxon, ANOVA where appropriate) to assess significance. Use regression analysis to identify predictors of image quality while adjusting dose.
- Perform a qualitative assessment via focus groups with radiographers to understand usability, acceptance, and workflow impact.
- Synthesize findings to evaluate safety, effectiveness, and operational feasibility.
What contribution the study will make: It will provide real-world evidence on the feasibility, safety, and efficacy of AI-based dose optimization in a tertiary hospital setting, identify implementation enablers and barriers, and offer guidance for scaling AI dose tools in radiology.
Expected outcome: A demonstrated reduction in patient dose without compromising diagnostic quality, along with actionable recommendations for workflow integration, monitoring, and governance.